6483.TWO Original BioMedicals Co., Ltd.

Healthcare Drug Manufacturers - Specialty & Generic Taiwan OTC Exchange
15.25 TWD
Close of Nov 6, 2026
11.00 20.00
Market cap
TWD 1.02B
P/E
-
P/B
9.36x
ROE
-64.3%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is 6483.TWO undervalued?

Graham number

The Graham number of Original BioMedicals Co., Ltd. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Original BioMedicals Co., Ltd. fundamental analysis

No fundamental analysis for Original BioMedicals Co., Ltd. yet.

Original BioMedicals Co., Ltd. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Original BioMedicals Co., Ltd.

Original BioMedicals Co., Ltd. engages in the development of drugs in Taiwan. The company develops OBM-A01, a radiation injury prevention and therapeutic drug for the treatment of acute radiation injuries, including nuclear radiation and solar radiation exposure in space; OBM-B01, a cyanide compound drug for protection against toxic gases from fires; CCM-CL, a cyclic polypeptide antibiotic; and Iron Dextran, an injection for the treatment of iron deficiency. It also provides…

Full company profile